Molecular Subtype Identification and Prognosis Stratification Based on Lysosome-related Genes in Breast Cancer

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Feb 29

PMID 38420434

Authors

Xiaozhen Liu

Kewang Sun

Hongjian Yang

Dehomg Zou

Lingli Xia

Kefeng Lu

Xuli Meng

Yongfeng Li

Affiliations

Soon will be listed here.

Abstract

Background: Lysosomes are known to have a significant impact on the development and recurrence of breast cancer. However, the association between lysosome-related genes (LRGs) and breast cancer remains unclear. This study aims to explore the potential role of LRGs in predicting the prognosis and treatment response of breast cancer.

Methods: Breast cancer gene expression profile data and clinical information were downloaded from TCGA and GEO databases, and prognosis-related LRGs were screened for consensus clustering analysis. Lasso Cox regression analysis was used to construct risk features derived from LRGs, and immune cell infiltration, immune therapy response, drug sensitivity, and clinical pathological feature differences were evaluated for different molecular subtypes and risk groups. A nomogram based on risk features derived from LRGs was constructed and evaluated.

Results: Our study identified 176 differentially expressed LRGs that are associated with breast cancer prognosis. Based on these genes, we divided breast cancer into two molecular subtypes with significant prognostic differences. We also found significant differences in immune cell infiltration between these subtypes. Furthermore, we constructed a prognostic risk model consisting of 7 LRGs, which effectively divides breast cancer patients into high-risk and low-risk groups. Patients in the low-risk group have better prognostic characteristics, respond better to immunotherapy, and have lower sensitivity to chemotherapy drugs, indicating that the low-risk group is more likely to benefit from immunotherapy and chemotherapy. Additionally, the risk score based on LRGs is significantly correlated with immune cell infiltration, including CD8 T cells and macrophages. This risk score model, along with age, chemotherapy, clinical stage, and N stage, is an independent prognostic factor for breast cancer. Finally, the nomogram composed of these factors has excellent performance in predicting overall survival of breast cancer.

Conclusions: In conclusion, this study has constructed a novel LRG-derived breast cancer risk feature, which performs well in prognostic prediction when combined with clinical pathological features.

Citing Articles

ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in glioma.

Xi Y, Yang Q, Wang Y, An W, Huang X, Sun C J Transl Med. 2025; 23(1):185.

PMID: 39953597 PMC: 11829375. DOI: 10.1186/s12967-025-06202-1.

References

Mathieu M, Mazouni C, Kesty N, Zhang Y, Scott V, Passeron J . Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy. Ann Oncol. 2011; 23(8):2046-2052. DOI: 10.1093/annonc/mdr550. View

Zhang S, Lee S, Nie L, Huang Y, Zou G, Jung Y . Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis. Cancer Commun (Lond). 2022; 43(1):159-163. PMC: 9859727. DOI: 10.1002/cac2.12382. View

Dielschneider R, Henson E, Gibson S . Lysosomes as Oxidative Targets for Cancer Therapy. Oxid Med Cell Longev. 2017; 2017:3749157. PMC: 5516749. DOI: 10.1155/2017/3749157. View

Martinez J, Malireddi R, Lu Q, Cunha L, Pelletier S, Gingras S . Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol. 2015; 17(7):893-906. PMC: 4612372. DOI: 10.1038/ncb3192. View

Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, De Wind A . CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013; 123(7):2873-92. PMC: 3696556. DOI: 10.1172/JCI67428. View

Mahapatra K, Mishra S, Behera B, Patil S, Gewirtz D, Bhutia S . The lysosome as an imperative regulator of autophagy and cell death. Cell Mol Life Sci. 2021; 78(23):7435-7449. PMC: 11071813. DOI: 10.1007/s00018-021-03988-3. View

Appelqvist H, Waster P, Kagedal K, Ollinger K . The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol. 2013; 5(4):214-26. DOI: 10.1093/jmcb/mjt022. View

Vizovisek M, Fonovic M, Turk B . Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond. Matrix Biol. 2018; 75-76:141-159. DOI: 10.1016/j.matbio.2018.01.024. View

Xiao X, Wang W, Li Y, Yang D, Li X, Shen C . HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018; 37(1):201. PMC: 6114771. DOI: 10.1186/s13046-018-0880-6. View

10.

Yim L, Lam K, Luk T, Mo Y, Lu X, Wang J . Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4 T Cells. J Virol. 2023; 97(5):e0027023. PMC: 10231204. DOI: 10.1128/jvi.00270-23. View

11.

Waks A, Winer E . Breast Cancer Treatment: A Review. JAMA. 2019; 321(3):288-300. DOI: 10.1001/jama.2018.19323. View

12.

Bekampyte J, Bartnykaite A, Savukaityte A, Ugenskiene R, Korobeinikova E, Gudaitiene J . The Investigation of Associations between rs1042522, rs2032809, rs9344, rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis. Diagnostics (Basel). 2021; 11(8). PMC: 8393676. DOI: 10.3390/diagnostics11081419. View

13.

Zhang W, Liu Z, Xia S, Yao L, Li L, Gan Z . is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma. Aging (Albany NY). 2021; 13(23):25304-25324. PMC: 8714169. DOI: 10.18632/aging.203748. View

14.

Radisavljevic Z . Lysosome activates AKT inducing cancer and metastasis. J Cell Biochem. 2019; 120(8):12123-12127. DOI: 10.1002/jcb.28752. View

15.

Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C . Follicular helper-T cells restore CD8-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy. J Immunother Cancer. 2021; 9(6). PMC: 8190041. DOI: 10.1136/jitc-2020-002157. View

16.

Liu C, Wang W, Lin P, Xie H, Jiang S, Jia H . GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway. Biochem Biophys Res Commun. 2021; 562:119-126. DOI: 10.1016/j.bbrc.2021.05.015. View

17.

Chen Y, Lu Y, Huang C, Wu J, Shao Y, Wang Z . Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma. Front Genet. 2023; 14:1149995. PMC: 10166181. DOI: 10.3389/fgene.2023.1149995. View

18.

Zhou Y, Zhou X, Hong T, Qi W, Zhang K, Geng F . Lysosome-mediated mitochondrial apoptosis induced by tea polysaccharides promotes colon cancer cell death. Food Funct. 2021; 12(21):10524-10537. DOI: 10.1039/d1fo00987g. View

19.

Yang Y, Wang Q, Song D, Zen R, Zhang L, Wang Y . Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway. J Exp Clin Cancer Res. 2020; 39(1):197. PMC: 7510096. DOI: 10.1186/s13046-020-01701-z. View

20.

Liu Z, Zheng W, Liu Y, Zhou B, Zhang Y, Wang F . Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells. Exp Cell Res. 2021; 405(2):112708. DOI: 10.1016/j.yexcr.2021.112708. View